Home/Filings/4/0001415889-23-012271
4//SEC Filing

GRAHAM RICHARD A 4

Accession 0001415889-23-012271

CIK 0001583107other

Filed

Aug 14, 8:00 PM ET

Accepted

Aug 15, 6:09 PM ET

Size

4.7 KB

Accession

0001415889-23-012271

Insider Transaction Report

Form 4
Period: 2023-08-11
GRAHAM RICHARD A
SVP, Development
Transactions
  • Sale

    Ordinary Shares

    2023-08-11$9.99/sh2,322$23,197349,746 total
Footnotes (1)
  • [F1]This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22.

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1
  • filerCIK 0001820036

Filing Metadata

Form type
4
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 6:09 PM ET
Size
4.7 KB